Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers
Remdesivir intermediates CAS NO. 1355357-49-1, Remdesivir N-4 intermediate for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation
Remdesivir, also known as GS-5734, is a novel antiviral drug in the class of nucleotide analogs developed by Gilead Sciences. In February 2020 Remdesivir was being studied for
experimental treatment of the emergent COVID-19 (novel coronavirus) disease.
Find More Remdesivir Intermediates>>>
I want to comment